Skip to main content

Animations

MJFF Publications

6691 - 6700 of 8808 Results
Title
Year
  • Year
  • 2021
  • 2020
  • 2021
  • 2020
  • 2021
  • 2025
  • 2025
  • 2025
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Further Characterization of Glycoform-Selective Prions of Variably Protease-Sensitive Prionopathy
    Journal Name: Pathogens
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/pathogens10050513
    Citation Count: 11
  • Summary Details
    OPEN
    Title: [11C]MODAG-001—towards a PET tracer targeting α-synuclein aggregates
    Journal Name: European Journal of Nuclear Medicine and Molecular Imaging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00259-020-05133-x
    Citation Count: 75
  • Summary Details
    OPEN
    Title: Cell-Type Specific Changes in DNA Methylation of SNCA Intron 1 in Synucleinopathy Brains
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2021.652226
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Impact of age and sex correction on the diagnostic performance of dopamine transporter SPECT
    Journal Name: European Journal of Nuclear Medicine and Molecular Imaging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00259-020-05085-2
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Genome-Wide Association Study Meta-Analysis for Parkinson Disease Motor Subtypes
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000000557
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Active Learning-Guided Hit Optimization for the Leucine-Rich Repeat Kinase 2 WDR Domain Based on In Silico Ligand-Binding Affinities
    Journal Name: Journal of Chemical Information and Modeling
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acs.jcim.5c00588
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Wrist accelerometry and machine learning sensitively capture disease progression in prodromal Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-025-01034-8
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Dopamine Transporter Imaging as Objective Monitoring Biomarker in Parkinson's Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/ana.27223
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Safety and Tolerability of Burst-Cycling Deep Brain Stimulation for Freezing of Gait in Parkinson’s Disease
    Journal Name: Frontiers in Human Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnhum.2021.651168
    Citation Count: 10
  • Summary Details
    OPEN
    Title: DNA Methylation and Expression Profiles of Whole Blood in Parkinson’s Disease
    Journal Name: Frontiers in Genetics
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fgene.2021.640266
    Citation Count: 59
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.